blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2881112

EP2881112 - PHARMACEUTICAL COMPOSITION FOR PROMOTING NERVE INJURY RESTORATION AND APPLICATION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.09.2020
Database last updated on 26.03.2026
FormerThe patent has been granted
Status updated on  11.10.2019
FormerGrant of patent is intended
Status updated on  12.06.2019
FormerExamination is in progress
Status updated on  13.07.2018
FormerRequest for examination was made
Status updated on  16.12.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Huang, Tongge
Room 104
Block 36 Yulan Shanzhuang
Yuhuatai
Nanjing
Jiangsu 210000 / CN
[2016/01]
Former [2015/24]For all designated states
Yue, Maoxing
No.9 North Anxiang Road
Chaoyang, Beijing 100101 / CN
For all designated states
Wan, Honggui
Room 1602, No.198 Qingshi City
Gulou, Nanjing
Jiangsu 210009 / CN
For all designated states
Huang, Tongge
Room 104
Block 36 Yulan Shanzhuang
Yuhuatai
Nanjing
Jiangsu 210000 / CN
Inventor(s)01 / YUE, Maoxing
No.9 North Anxiang Road
Chaoyang, Beijing 100101 / CN
02 / WAN, Honggui
Room 1602, No.198 Qingshi City
Gulou, Nanjing Jiangsu 210009 / CN
03 / HUANG, Tongge
Room 104
Block 36 Yulan Shanzhuang
Yuhuatai
Nanjing Jiangsu 210000 / CN
 [2016/01]
Former [2015/24]01 / see applicant
...
Representative(s)Engelhard, Markus
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2019/46]
Former [2015/24]Engelhard, Markus
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Patentanwälte Rechtsanwälte
Pettenkoferstrasse 20-22
80336 München / DE
Application number, filing date12882373.923.08.2012
[2019/46]
WO2012CN80517
Priority number, dateCN20121027272401.08.2012         Original published format: CN201210272724
[2015/24]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014019268
Date:06.02.2014
Language:ZH
[2014/06]
Type: A1 Application with search report 
No.:EP2881112
Date:10.06.2015
Language:EN
[2015/24]
Type: B1 Patent specification 
No.:EP2881112
Date:13.11.2019
Language:EN
[2019/46]
Search report(s)International search report - published on:CN06.02.2014
(Supplementary) European search report - dispatched on:EP12.02.2016
ClassificationIPC:A61K31/198, A61K31/4415, A61P25/00
[2015/24]
CPC:
A61K31/198 (EP,US); A61K31/4415 (EP,US); A61K9/0019 (EP,US);
A61P25/00 (EP); A61K47/02 (EP,US); A61K47/26 (EP,US)
C-Set:
A61K31/198, A61K2300/00 (EP,US);
A61K31/4415, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/24]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR FÖRDERUNG VON NERVENSCHÄDENWIEDERHERSTELLUNGEN UND VERWENDUNG DAVON[2015/24]
English:PHARMACEUTICAL COMPOSITION FOR PROMOTING NERVE INJURY RESTORATION AND APPLICATION THEREOF[2015/24]
French:COMPOSITION PHARMACEUTIQUE POUR PROMOUVOIR LA RESTAURATION D'UNE LÉSION NERVEUSE ET SON APPLICATION[2015/24]
Entry into regional phase24.02.2015Translation filed 
24.02.2015National basic fee paid 
24.02.2015Search fee paid 
24.02.2015Designation fee(s) paid 
24.02.2015Examination fee paid 
Examination procedure24.02.2015Examination requested  [2015/24]
09.09.2016Amendment by applicant (claims and/or description)
17.07.2018Despatch of a communication from the examining division (Time limit: M06)
25.01.2019Reply to a communication from the examining division
13.06.2019Communication of intention to grant the patent
07.10.2019Fee for grant paid
07.10.2019Fee for publishing/printing paid
07.10.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.07.2018
Opposition(s)14.08.2020No opposition filed within time limit [2020/43]
Fees paidRenewal fee
24.02.2015Renewal fee patent year 03
10.08.2015Renewal fee patent year 04
11.08.2016Renewal fee patent year 05
25.08.2017Renewal fee patent year 06
10.08.2018Renewal fee patent year 07
20.08.2019Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.08.2012
AL13.11.2019
CY13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
MC13.11.2019
MK13.11.2019
MT13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
[2022/32]
Former [2022/27]HU23.08.2012
AL13.11.2019
CY13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
MC13.11.2019
MT13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2021/18]AL13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
MC13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/51]AL13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SI13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/37]AL13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
SK13.11.2019
SM13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/36]AL13.11.2019
CZ13.11.2019
DK13.11.2019
EE13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/35]AL13.11.2019
CZ13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RO13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/32]AL13.11.2019
FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/25]FI13.11.2019
HR13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
RS13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/24]FI13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
IS13.03.2020
PT13.03.2020
Former [2020/23]FI13.11.2019
LT13.11.2019
LV13.11.2019
PL13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
PT13.03.2020
Former [2020/22]FI13.11.2019
LT13.11.2019
SE13.11.2019
BG13.02.2020
NO13.02.2020
PT13.03.2020
Former [2020/21]NO13.02.2020
Documents cited:Search[E] EP2601951  (YUE MAOXING et al.) [E] 1-6 * page 3, paragraphs 14-17 * * claims 1-3 *
 [IY] US2006083727  (KAJANDER E O et al.) [I] 7-9 * page 3, paragraphs 19-20 *[Y] 1-6
 [Y] US2007286909  (SMITH DANIEL S et al.) [Y] 1-6 * page 5; table 3 *
International search[X] CN101912394  (MAOXING YUE et al.) [X]
ExaminationWO2012016408
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.